NCT04737941 Finnish Venous Ulcer Study (FINNULCER Study)
| NCT ID | NCT04737941 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Oulu University Hospital |
| Condition | Venous Leg Ulcer |
| Study Type | INTERVENTIONAL |
| Enrollment | 248 participants |
| Start Date | 2021-02-26 |
| Primary Completion | 2025-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 248 participants in total. It began in 2021-02-26 with a primary completion date of 2025-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This multicenter randomized controlled trial evaluates the effect of first-visit foam sclerotherapy (including sub-ulcer foam sclerotherapy) in patients with venous leg ulcer.
Eligibility Criteria
Inclusion Criteria: * Patient informed consent * Venous ulcer, aged from one month to one year * Duplex ultrasonography verified (vein reflux greater than \>0.5 second) superficial venous insufficiency * Sufficient arterial circulation (at least on criterion met: Palpable distal pulses / ankle-brachial index \> 0,8 / Toe pressure \>60mmhg) Exclusion Criteria: * Leg ulcers other than venous etiology * Ulcers requiring operation theater revision * Patent foramen ovale * Several times recurrent (over 3 recurrences) venous ulcer * Body Mass Index over 40 * Pregnancy
Contact & Investigator
Toni Pihlaja, MD
PRINCIPAL INVESTIGATOR
Oulu University Hospital
Frequently Asked Questions
Who can join the NCT04737941 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Venous Leg Ulcer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04737941 currently recruiting?
Yes, NCT04737941 is actively recruiting participants. Contact the research team at matti.pokela@ppshp.fi for enrollment information.
Where is the NCT04737941 trial being conducted?
This trial is being conducted at Helsinki, Finland, Jyväskylä, Finland, Oulu, Finland, Turku, Finland and 1 additional location.
Who is sponsoring the NCT04737941 clinical trial?
NCT04737941 is sponsored by Oulu University Hospital. The principal investigator is Toni Pihlaja, MD at Oulu University Hospital. The trial plans to enroll 248 participants.